Injectable Drug Delivery Market to See Huge Growth by 2025 | Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz

The report aims to provide an overview of the Global Injectable Drug Delivery Market along with detailed segmentation of the market by applications, end-users and five major geographical regions. Global Injectable Drug Delivery Market is expected to witness aggressive growth during the forecast period.

Leading players of Injectable Drug Delivery Market:
Baxter International, Inc., Becton Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Ypsomed, and Bespak, among other players

Get Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-injectable-drug-delivery-market

Global Injectable Drug Delivery Market is expected to reach USD 1,104,096.5 Million by 2025 from USD 378,998.2 Million in 2017, at a CAGR of 12.4% in the forecast period 2018 to 2025. Global Injectable Drug Delivery Market, Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Application (Hormonal Disorders, orphan disease, other applications), Usage Pattern, Mode Of Administration, End User (Hospitals And Clinics, Home Healthcare Settings, Research Laboratories, Pharmaceutical And Biotechnological Companies, Other End Users), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tender, Online Pharmacy),Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2025

The major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market.

Market Segmentation: Global Injectable Drug Delivery Market

• The global injectable drug delivery market is segmented on of type, portability, type, product type, application, usage pattern, mode of administration, end user, distribution channel, and geography. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.

• The global injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation. The Injectable drug delivery market is dominated by formulations with 75.7% market share in 2018, growing at a CAGR of 12.4% and will cross USD 837,873.64 million by 2025.

• On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others. The Injectable drug delivery market is dominated by hormonal disorders with 50.1% market share in 2018, growing at a CAGR of 12.1% and will cross USD 540,977.35 million by 2025. However, oncology segment is expected to grow at the highest CAGR of 13.6% in the forecast period, and is expected to reach USD 265,145.17 million in 2025 from USD 82,915.00 million in 2017

• On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern. The Injectable drug delivery market is dominated by curative care with 93.2% market share in 2018, growing at a CAGR of 12.5% and will cross USD 1,036,829.49 million by 2025.

• On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system. The Injectable drug delivery market is dominated by skin with 46.8% market share in 2018, growing at a CAGR of 12.8% and will cross USD 532,193.0 million by 2025. However, circulatory/musculoskeletal segment is expected to grow at the highest CAGR of 12.6% in the forecast period, and is expected to reach USD 385,832.9 million in 2025 from USD 130,812.6 million in 2017

• On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. The Injectable drug delivery market is dominated by hospitals & clinics with 62.6% market share in 2018, growing at a CAGR of 12.5% and will cross USD 693,323.05 million by 2025.

• On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, and direct tender and online pharmacy. The Injectable drug delivery market is dominated by direct tenders with 69.2% market share in 2018, growing at a CAGR of 12.7% and will cross USD 780,682.75 million by 2025. However, pharmacy stores segment is expected to grow at the highest CAGR of 13.5% in the forecast period, and is expected to reach USD 142,617.48 million in 2025 from USD 44,812.56 million in 2017

• Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

To Buy Complete Report Click Here @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-injectable-drug-delivery-market

Key Points: Global Injectable Drug Delivery Market

Baxter International, Inc., Becton Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Ypsomed, and Bespak, among other players

• Formulations are expected to dominate the global Injectable drug delivery market with the market share of 75.7%

• Plastics in the global injectable drug delivery devices market are driving the market with a CAGR Of 11.2%

Table of Contents:

1. INTRODUCTION
1.1. OVERVIEW OF GLOBAL INJECTABLE DRUG DELIVERY MARKET 1.2. CURRENCY AND PRICING 1.3. LIMITATION 1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCES 2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF CHRONIC DISEASES 3.1.2. RISING DEMAND OF SELF-INJECTION DEVICES 3.1.3. GROWTH OF BIOLOGICS MARKET 3.1.4. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
3.2. RESTRAINTS
3.2.1. NEEDLESTICK INJURIES AND INFECTIONS 3.2.2. HIGH COST OF DEVELOPMENT 3.2.3. STRICT REGULATORY FRAMEWORK 3.3. OPPORTUNITY 3.3.1. INCREASING DEMAND FOR GENERIC AND BIOSIMILAR DRUGS 3.3.1.1. GENERICS 3.3.1.2. BIOSIMILARS 3.3.2. INCREASING DEMAND FOR CONTRACEPTIVE INJECTABLES 3.3.3. INCREASING DEMAND FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. ALTERNATIVE ROUTE OF DRUG ADMINISTRATION 3.4.2. PRODUCT RECALL 3.4.3. STABILITY OF PRODUCTS 3.4.4. STERILITY OF INJECTIONS
4. EXECUTIVE SUMMARY 5. PREMIUM INSIGHTS 6. GLOBAL INJECTABLE DRUG DELIVERY MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL 6.3. CE MARKING (EUROPEAN CONFORMITY) 6.4. EM (EUROPEAN MEDICINE AGENCY)
7. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY TYPE
8. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
9. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN
10. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION
11. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY END USER
12. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
13. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY
14. GLOBAL INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE
15. COMPANY PROFILES

View Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-injectable-drug-delivery-market

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.